DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
基本信息
- 批准号:10206240
- 负责人:
- 金额:$ 45.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAnimal ModelApoptosisAttenuatedAutophagocytosisBMPR2 geneBiologicalBlood VesselsCell NucleusCell ProliferationCell physiologyCellsClinicalCytokine SignalingCytoplasmDevelopmentDiabetes MellitusDiseaseDown-RegulationEpigenetic ProcessEtiologyEventExocytosisFOXO1A geneFeedbackFunctional disorderGene ExpressionGenetic TranscriptionGoalsHMGB1 ProteinHMGB1 geneHistologicHomologous GeneHumanHypoxiaImmuneImmune responseIn VitroInflammationInflammatoryInflammatory ResponseInjuryInterleukin-2LeadLungMalignant NeoplasmsMediatingMediator of activation proteinModificationMolecularMusNuclearNuclear TranslocationPathologicPatientsPatternPeripheral Blood Mononuclear CellPlayProcessProductionPropertyProteinsPublishingPulmonary HypertensionPulmonary artery structureReceptor ActivationRegulationResistanceRodentRodent ModelRoleS100 Calcium Binding ProteinS100 ProteinsS100A11 geneSIRT1 geneSclerodermaSerumSignal TransductionSignaling MoleculeSignaling ProteinSlideSmooth Muscle MyocytesSpecimenStructure of parenchyma of lungVascular remodelingWorkautocrinebone morphogenetic protein receptorscell motilityclinically significantdiagnostic biomarkerextracellularhemodynamicsimmunoregulationin vivomouse resistin-like alphanovel therapeutic interventionnovel therapeuticsparacrinereceptor for advanced glycation endproductsresistinresponsetraffickingvascular inflammation
项目摘要
SUMMARY
Hypoxia-induced mitogenic factor (HIMF; also known as FIZZ1 or resistin-like molecule-) is critical to
pulmonary hypertension (PH) development in rodent models, and our work suggests that HIMF may trigger a
positive feedback loop to amplify the vascular inflammation required for remodeling. We have implicated the
human homolog of HIMF, human resistin (hresistin) in human idiopathic and scleroderma related PH. Several
downstream vascular and immune processes critical to rodent and human PH are activated by HIMF and
hresistin but the manner in which HIMF/hresistin initiates these responses in a pathologic manner remains
unknown. Damage-associated molecular pattern molecules (DAMPs), including high mobility group box
(HMGB)1 and S100 calcium binding proteins, act as endogenous danger signals to regulate the subsequent
inflammatory response through an autocrine and paracrine manner via activation of the receptor for advanced
glycation end-products (RAGE). We now show HIMF and hresistin-induced HMGB1 and S100A11 activation in
human vascular and immune cells related to PH and in PH animal models. However the mechanism of
HIMF/hresistin regulation of this response and the function of the HIMF/DAMP/RAGE signaling axis during PH
development remain unclear. In preliminary studies, we found that HIMF signaling activates HMGB1/RAGE
axis in vivo and in vitro in association with suppressed sirtuin (Sirt)1, enhanced autophagy, attenuated
expression of forkhead box O (FoxO)1 and bone morphogenetic protein receptor (BMPR)2, and hyper-
proliferation of pulmonary artery smooth muscle cells (PASMC). In addition, in our preliminary studies another
DAMP, the S100A11, also has been found to increase in peripheral blood mononuclear cells of PH patients.
In this proposal, we hypothesize that HIMF/hresistin activated DAMP signaling mediates the cross-
talk between vascular cells and immune cells, initiates an autophagic response, and downregulates
FoxO1 and BMPR2, thereby contributing to PH pathophysiology. We will investigate the role of DAMPs
in HIMF-induced inflammatory response and subsequent vascular remodeling by illustrating their
cellular and molecular signaling processes initiated by HIMF and elucidating the underlying
mechanism. The three related specific aims are directed at understanding: (1) the roles of HIMF in
mediating the intracellular and extracellular activity and the epigenetic modification of DAMP molecules; (2) the
downstream events of the HIMF/DAMP signaling axis, including autophagy/apoptosis regulation, BMPR2 and
FoxO1 downregulation and their possible interaction; and (3) the expression/production of DAMPs and their
downstream mediators in PH development, as well as the correlation of these molecules in existing clinical PH
patient specimens. The goal of this proposal is to further clarify the relation between the immunomodulatory
properties of HIMF and the etiology of PH, and thereby to explore a novel therapeutic approach for PH and
other vascular inflammation-related diseases.
概括
缺氧诱导的有丝分裂因子(HIMF;也称为 FIZZ1 或抵抗素样分子-α)对于
啮齿动物模型中肺动脉高压(PH)的发展,我们的工作表明 HIMF 可能会引发
正反馈环路放大了重塑所需的血管炎症。
HIMF 的人类同源物,人类特发性和硬皮病相关 PH 中的人类抵抗素 (hresistin)。
HIMF 激活对啮齿动物和人类 PH 至关重要的下游血管和免疫过程,
hresistin,但 HIMF/hresistin 以病理方式启动这些反应的方式仍然存在
未知的损伤相关分子模式分子(DAMP),包括高迁移率族盒。
(HMGB)1和S100钙结合蛋白,作为内源性危险信号来调节随后的
通过激活晚期受体,通过自分泌和旁分泌方式产生炎症反应
我们现在显示 HIMF 和 hresistin 诱导的 HMGB1 和 S100A11 激活。
然而,人类血管和免疫细胞与 PH 以及 PH 动物模型中的机制有关。
HIMF/hresistin 对该反应的调节以及 PH 期间 HIMF/DAMP/RAGE 信号轴的功能
在初步研究中,我们发现 HIMF 信号激活 HMGB1/RAGE。
体内和体外轴与抑制的沉默调节蛋白(Sirt)1相关,增强自噬,减弱
叉头框 O (FoxO)1 和骨形态发生蛋白受体 (BMPR)2 的表达,以及超
另外,在我们的初步研究中,肺动脉平滑肌细胞(PASMC)的增殖。
DAMP(S100A11)也被发现会增加 PH 患者的外周血单核细胞。
在这个提案中,我们研究了 HIMF/hresistin 激活的 DAMP 信号传导介导的交叉
血管细胞和免疫细胞之间的对话,启动自噬反应,并下调
FoxO1 和 BMPR2,从而促进 PH 病理生理学 我们将研究 DAMP 的作用。
通过说明其在 HIMF 诱导的炎症反应和随后的血管重塑中的作用
HIMF 启动的细胞和分子信号传导过程并阐明其潜在机制
三个相关的具体目标旨在理解:(1)HIMF 在以下方面的作用:
(2)介导DAMP分子的细胞内和细胞外活性以及表观遗传修饰;
HIMF/DAMP 信号轴的下游事件,包括自噬/凋亡调节、BMPR2 和
FoxO1 下调及其可能的相互作用;以及 (3) DAMP 的表达/产生及其可能的相互作用;
PH发展中的下游介质,以及这些分子与现有临床PH的相关性
该提案的目的是进一步阐明免疫调节之间的关系。
HIMF 的特性和 PH 的病因学,并探索治疗 PH 和 PH 的新方法
其他血管炎症相关疾病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure.
EXPRESS:肺动脉高压中的右心:从适应到衰竭。
- DOI:
- 发表时间:2019-04-03
- 期刊:
- 影响因子:2.6
- 作者:Ren, Xianfeng;Johns, Roger A;Gao, Wei Dong
- 通讯作者:Gao, Wei Dong
Resistin-Like Molecule α Dysregulates Cardiac Bioenergetics in Neonatal Rat Cardiomyocytes.
抵抗素样分子 α 调节新生大鼠心肌细胞中的心脏生物能学。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Tao, Bingdong;Kumar, Santosh;Gomez;Fan, Chunling;Zhang, Ailan;Skinner, John;Hunter, Elizabeth;Yamaji;Samad, Idris;Hillel, Alexander T;Lin, Qing;Zhai, Wenqian;Gao, Wei Dong;Johns, Roger A
- 通讯作者:Johns, Roger A
Human Resistin Induces Cardiac Dysfunction in Pulmonary Hypertension.
人类抵抗素在肺动脉高压中诱发心脏功能障碍。
- DOI:
- 发表时间:2023-03-21
- 期刊:
- 影响因子:5.4
- 作者:Lin, Qing;Kumar, Santosh;Kariyawasam, Udeshika;Yang, Xiaomei;Yang, Wei;Skinner, John T;Gao, Wei Dong;Johns, Roger A
- 通讯作者:Johns, Roger A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger A Johns其他文献
Roger A Johns的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger A Johns', 18)}}的其他基金
Resistin regulates NLRP3 inflammasome in pulmonary hypertension
抵抗素调节肺动脉高压中的 NLRP3 炎性体
- 批准号:
10567914 - 财政年份:2023
- 资助金额:
$ 45.49万 - 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
- 批准号:
9976575 - 财政年份:2018
- 资助金额:
$ 45.49万 - 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
- 批准号:
8931049 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10649603 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
- 批准号:
8673354 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
- 批准号:
9016565 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
- 批准号:
8757198 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10212402 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10390873 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
- 批准号:
10212402 - 财政年份:2014
- 资助金额:
$ 45.49万 - 项目类别:
相似国自然基金
组织器官衰老致退行性演变多示踪剂全身动态PET显像研究
- 批准号:91949121
- 批准年份:2019
- 资助金额:68.0 万元
- 项目类别:重大研究计划
N-甲基-N-亚硝脲诱导眼科疾病动物模型的潜能探索及治疗保护策略研究
- 批准号:81770887
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
Slug参与CP-31398介导的p53突变型子宫内膜癌细胞凋亡的机制研究
- 批准号:81702967
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
Fascin-2基因TALEN敲除小鼠渐进性听力减退的机制研究
- 批准号:81771020
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
噪声介导COX2激活抑制Nrf2/ARE信号通路在促进耳蜗毛细胞死亡中的作用机制及干预研究
- 批准号:81600807
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors
用于靶向治疗非典型畸胎瘤/横纹肌样瘤的 IGF-1R 靶向肽药物缀合物
- 批准号:
10760549 - 财政年份:2023
- 资助金额:
$ 45.49万 - 项目类别:
Small molecule approach to activate human SIRT5
激活人类 SIRT5 的小分子方法
- 批准号:
10443067 - 财政年份:2022
- 资助金额:
$ 45.49万 - 项目类别:
Regulation of Ku70 methylation and functions by SETD4
SETD4 对 Ku70 甲基化和功能的调节
- 批准号:
10228239 - 财政年份:2021
- 资助金额:
$ 45.49万 - 项目类别:
Regulation of Ku70 methylation and functions by SETD4
SETD4 对 Ku70 甲基化和功能的调节
- 批准号:
10546482 - 财政年份:2021
- 资助金额:
$ 45.49万 - 项目类别:
Regulation of Ku70 methylation and functions by SETD4
SETD4 对 Ku70 甲基化和功能的调节
- 批准号:
10330477 - 财政年份:2021
- 资助金额:
$ 45.49万 - 项目类别: